These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1747294)

  • 1. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
    Jansson JH; Nilsson TK; Johnson O
    Br Heart J; 1991 Nov; 66(5):351-5. PubMed ID: 1747294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.
    Jansson JH; Nilsson TK; Johnson O
    Heart; 1998 Oct; 80(4):334-7. PubMed ID: 9875107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.
    Hamsten A; de Faire U; Walldius G; Dahlén G; Szamosi A; Landou C; Blombäck M; Wiman B
    Lancet; 1987 Jul; 2(8549):3-9. PubMed ID: 2885513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue plasminogen activator as a prognostic factor in myocardial infarct patients].
    Fernández Abellán P; Marín Ortuño F; Marco Vera P; Luján Martínez J
    Rev Clin Esp; 1999 Apr; 199(4):215-7. PubMed ID: 10364793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
    Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
    J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extrinsic fibrinolytic system in survivors of myocardial infarction.
    Nilsson TK; Johnson O
    Thromb Res; 1987 Dec; 48(6):621-30. PubMed ID: 3124290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase.
    Nilsson JB; Boman K; Jansson JH; Nilsson T; Näslund U
    J Thromb Thrombolysis; 2008 Dec; 26(3):188-95. PubMed ID: 17721741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.
    Gram J; Jespersen J; Kluft C; Rijken DC
    Acta Med Scand; 1987; 221(2):149-53. PubMed ID: 3591453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between fibrinolytic function and acute myocardial infarction.
    Wiman B; Hamsten A
    Am J Cardiol; 1990 Nov; 66(16):54G-56G. PubMed ID: 2122704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction.
    Andreotti F; Hackett DR; Haider AW; Roncaglioni MC; Davies GJ; Beacham JL; Kluft C; Maseri A
    Thromb Haemost; 1992 Dec; 68(6):678-82. PubMed ID: 1287882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
    Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarction.
    Pedersen OD; Munkvad S; Gram J; Kluft C; Jespersen J
    Eur Heart J; 1993 Jun; 14(6):785-9. PubMed ID: 8325306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
    Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG
    Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
    Blann AD; Porter M; McCollum CN
    Br Heart J; 1992 Dec; 68(6):635-6. PubMed ID: 1467064
    [No Abstract]   [Full Text] [Related]  

  • 20. On the association of elevated tPA/PAI-1 complex and von Willebrand factor with recurrent myocardial infarction.
    Bounameaux H; Kruithof EK
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1857-9. PubMed ID: 10938004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.